Violence among youth in the United States has surged in the past two decades. Numerous
treatment programs exist to help treat the after-effects of violence, but by comparison, too few …

PURPOSE: Topotecan and cyclophosphamide, doxorubicin, and vincristine (CAV) were
evaluated in a randomized, multicenter study of patients with small-cell lung cancer (SCLC) who …

PURPOSE Topotecan and paclitaxel were evaluated in a randomized, multicenter study of
patients with advanced epithelial ovarian carcinoma who had progressed during or after one …

Introduction: Antagonists of activin receptor signaling may be beneficial for cancer-related
anemia and bone disease caused by malignancies such as multiple myeloma and solid …

PURPOSE Topotecan, a topoisomerase I inhibitor, was evaluated in a multicenter, phase II
study of women with epithelial ovarian carcinoma who relapsed after one or two prior …

Purpose: We conducted a single-center, dose-escalation study evaluating the safety,
pharmacokinetics, and efficacy of epratuzumab, an anti-CD22 humanized monoclonal antibody, in …

Background: The ultimate therapy for acute cholecystitis is cholecystectomy. However, in
critically ill elderly patients the mortality of emergency cholecystectomy may reach up to 30%. …

Makes practical recommendations regarding the implementation of outcome assessment in
the typical clinical setting. This book is geared toward the practitioner who conducts …

Four well defined multidrug-resistant cell lines and their drug-sensitive counterparts were
examined for intracellular distribution of daunorubicin (DNR) by laser-assisted confocal …

PURPOSE: A large, randomized study comparing the efficacy and safety of topotecan
versus paclitaxel in patients with relapsed epithelial ovarian cancer showed that these two …